Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-27T23:39:45.043Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life

Published online by Cambridge University Press:  08 March 2007

Astrid M. Bakker-Zierikzee ,
Martine S. Alles ,
Jan Knol ,
Frans J. Kok ,
Jules J. M. Tolboom  and
Jacques G. Bindels
Astrid M. Bakker-Zierikzee*
Affiliation:
Division of Human Nutrition, Wageningen University, PO Box 8129, NL-6700 EV, Wageningen, The Netherlands
Martine S. Alles
Affiliation:
Numico Research BV, Wageningen, The Netherlands
Jan Knol
Affiliation:
Numico Research BV, Wageningen, The Netherlands
Frans J. Kok
Affiliation:
Division of Human Nutrition, Wageningen University, PO Box 8129, NL-6700 EV, Wageningen, The Netherlands
Jules J. M. Tolboom
Affiliation:
Department of Paediatrics, University Medical Centre St Radboud, Nijmegen, The Netherlands
Jacques G. Bindels
Affiliation:
Division of Human Nutrition, Wageningen University, PO Box 8129, NL-6700 EV, Wageningen, The Netherlands Numico Research BV, Wageningen, The Netherlands
*
*Corresponding author: Dr A. M. Bakker-Zierikzee, fax +31 317 482782, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Adding prebiotics or probiotics to infant formula to improve the intestinal flora of formula-fed infants is considered to be a major innovation. Several companies have brought relevant formulations onto the market. However, comparative data on the effects of pre- and probiotics on the intestinal microflora of infants are not available. The present study aimed to compare the effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the composition and metabolic activity of the intestinal microflora. Before birth, infants were randomised and double blindly allocated to one of three formulas. The prebiotic (GOS/FOS) group (n 19) received regular infant formula supplemented with a mixture of galacto-oligosaccharides and fructo-oligosaccharides (6g/l). The probiotic (Bb-12) group (n 19) received the same formula supplemented with 6·0×1010 viable cells of B. animalis per litre. The standard group (n 19) received non-supplemented regular formula. A group of sixty-three breast-fed infants was included as a reference group. Faecal samples were taken at postnatal day 5 and 10, and week 4, 8, 12 and 16. Compared with the groups fed Bb-12 and standard formula, the GOS/FOS formula group showed higher faecal acetate ratio (69·7% (sem 2·7), 69·9% (sem 3·9) and 82·2% (sem 5·3); P<0·05) and lactate concentration (11·3 (sem 7·9), 3·1 (sem 2·3) and 34·7 (sem 10·7) mmol/kg faeces) and lower pH (6·6 (sem 0·2), 7·1 (sem 0·2) and 5·6 (sem 0·2); P<0·05) at 16 weeks. Differences in percentage of bifidobacteria between the GOS/FOS (59·2% (sem 7·7)), Bb-12 (52·7% (sem 8·0)) and the standard (51·8% (sem 6·4)) groups were not statistically significant at 16 weeks. Feeding infants GOS/FOS formula resulted in a similar effect on metabolic activity of the flora as in breast-fed infants. In the Bb-12 group, composition and metabolic activity of the flora were more similar to those of the standard group.

Keywords

InfantsPrebioticsProbioticsGalacto-oligosaccharidesFructo-oligosaccharidesBifidobacteriaShort-chain fatty acidsLactatepH
Type
Research Article
Information
British Journal of Nutrition , Volume 94 , Issue 5 , November 2005 , pp. 783 - 790
Copyright
Copyright © The Nutrition Society 2005

References

Adams, MR & Hall, CJ (1988) Growth inhibition of food-borne pathogens by lactic acid and acetic acid and their mixtures. Int J Food Sci Technol 23, 287–292.CrossRefGoogle Scholar
Alander, M, Matto, J, Kneifel, W, Johansson, M, Kogler, B, Crittenden, R, Mattila, ST & Saarela, M (2001) Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J 11, 817–825.CrossRefGoogle Scholar
Balmer, SE, Scott, PH & Wharton, BA (1989) Diet and faecal flora in the newborn: casein and whey proteins. Arch Dis Child 64, 1678–1684.CrossRefGoogle ScholarPubMed
Benno, Y, Sawada, K & Mitsuoka, T (1984) The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28, 975–986.CrossRefGoogle ScholarPubMed
Boehm, G, Lidestri, M, Casetta, P, Jelinek, J, Negretti, F, Stahl, B & Marini, A (2002) Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child 86, F178–F181.CrossRefGoogle ScholarPubMed
Brand, MJ, McVeagh, P, McNeil, Y & Messer, M (1998) Digestion of human milk oligosaccharides by healthy infants evaluated by the lactulose hydrogen breath test. J Pediatr 133, 95–98.CrossRefGoogle Scholar
Bullen, CL & Tearle, PV (1976) Bifidobacteria in the intestinal tract of infants: an in-vitro study. J Med Microbiol 9, 335–344.CrossRefGoogle ScholarPubMed
Chierici, R, Sawatzki, G, Thurl, S, Tovar, K & Vigi, V (1997) Experimental milk formulae with reduced protein content and desialylated milk proteins: influence on the faecal flora and the growth of term newborn infants. Acta Paediatr 86, 557–563.CrossRefGoogle ScholarPubMed
Edwards, CA, Parrett, AM, Balmer, SE & Wharton, BA (1994) Faecal short chain fatty acids in breast-fed and formula-fed babies. Acta Paediatr 83, 459–462.CrossRefGoogle ScholarPubMed
Eklund, T (1983) The anti microbial effect of dissociated and undissociated sorbic-acid at different pH levels. J Appl Bacteriol 54, 383–390.CrossRefGoogle Scholar
Engfer, MB, Stahl, B, Finke, B, Sawatzki, G & Daniel, H (2000) Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 71, 1589–1596.CrossRefGoogle ScholarPubMed
Ford, K & Labbok, M (1990) Implications of associated social and biomedical variables for research on the consequences of method of infant feeding. Am J Clin Nutr 52, 451–456.CrossRefGoogle ScholarPubMed
Fukushima, Y, Kawata, Y, Hara, H, Terada, A & Mitsuoka, T (1998) Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 42, 39–44.CrossRefGoogle ScholarPubMed
Fuller, R (1989) Probiotics in man and animals. J Appl Bacteriol 66, 365–378.Google Scholar
Gibson, GR & Roberfroid, MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401–1412.CrossRefGoogle ScholarPubMed
Harmsen, HJ, Wildeboer, VA, Raangs, GC, Wagendorp, AA, Klijn, N, Bindels, JG & Welling, GW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30, 61–67.CrossRefGoogle ScholarPubMed
Isolauri, E (2001) Probiotics in human disease. Am J Clin Nutr 73, 1142S–1146S.CrossRefGoogle ScholarPubMed
Isolauri, E, Arvola, T, Sutas, Y, Moilanen, E & Salminen, S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604–1610.CrossRefGoogle ScholarPubMed
Jansen, GJ, Wildeboer-Veloo, A-CM, Tonk, R-HJ, Franks, AH & Welling, GW (1999) Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria. J Microbiol Methods 37, 215–221.CrossRefGoogle ScholarPubMed
Kalliomaki, M, Salminen, S, Arvilommi, H, Kero, P, Koskinen, P & Isolauri, E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076–1079.CrossRefGoogle ScholarPubMed
Knol, J, Steenbakkers, BMA, van der Linde, EGM, Gross, S, Helm, K, Larczyk, M, Schopfer, H & Kafka, C (2002) Bifidobacterial species that are present in breast-fed infants are stimulated in formula fed infants by changing to a formula containing prebiotics. J Pediatr Gastroenterol Nutr 34, 477.Google Scholar
Knol, J, van der Linde, E, Wells, JCK & Bockler, HM (2003) An infant formula containing prebiotics changes the intestinal microflora of term infants. J Pediatr Gastroenterol Nutr 36, 566.Google Scholar
Langendijk, PS, Schut, F, Jansen, GJ, Raangs, GC, Kamphuis, GR, Wilkinson, MH & Welling, GW (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61, 3069–3075.CrossRefGoogle ScholarPubMed
Langhendries, JP, Detry, J, Van-Hees, J, Lamboray, JM, Darimont, J, Mozin, MJ, Secretin, MC & Senterre, J (1995) Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 21, 177–181.Google ScholarPubMed
Link-Amster, H, Rochat, F, Saudan, KY, Mignot, O & Aeschlimann, JM (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10, 55–63.CrossRefGoogle ScholarPubMed
MacLean, W-CJ, Fink, BB, Schoeller, DA, Wong, W & Klein, PD (1983) Lactose assimilation by full-term infants: relation of [13 C] and H 2 breath tests with fecal [13 C] excretion. Pediatr Res 17, 629–633.CrossRefGoogle Scholar
Moon, NJ (1983) Inhibition of the growth of acid tolerant yeasts by acetate, lactate and their synergistic mixtures. J Appl Bacteriol 77, 412–420.Google Scholar
Moro, G, Minoli, I, Mosca, M, Fanaro, S, Jelinek, J, Stahl, B & Boehm, G (2002) Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 34, 291–295.Google ScholarPubMed
Ogawa, K, Ben, RA, Pons, S, de-Paolo, MI & Bustos, FL (1992) Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants [see comments]. J Pediatr Gastroenterol Nutr 15, 248–252.Google ScholarPubMed
Saavedra, JM, Bauman, NA, Oung, I, Perman, JA & Yolken, RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344, 1046–1049.CrossRefGoogle ScholarPubMed
Satokari, RM, Vaughan, EE, Akkermans-Antoon, DL, Saarela, M & de-Vos-Willem, M (2001) Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal Bifidobacterium populations in a prebiotic and probiotic feeding trial. Syst Appl Microbiol 24, 227–231.CrossRefGoogle Scholar
Schiffrin, EJ, Rochat, F, Link-Amster, H, Aeschlimann, JM, Donnet-Hughes, A (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491–497.CrossRefGoogle ScholarPubMed
Schmelzle, H, Wirth, S, Skopnik, H, Radke, M, Knol, J, Bockler, HM, Bronstrup, A, Wells, J & Fusch, C (2003) Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high β-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 36, 343–351.Google ScholarPubMed
Siigur, U, Ormisson, A & Tamm, A (1993) Faecal short-chain fatty acids in breast-fed and bottle-fed infants. Acta Paediatr 82, 536–538.CrossRefGoogle ScholarPubMed
Stahl, B, Thurl, S, Zeng, J, Karas, M, Hillenkamp, F, Steup, M & Sawatzki, G (1994) Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 223, 218–226.CrossRefGoogle ScholarPubMed
Wang, X & Gibson, GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75, 373–380.CrossRefGoogle ScholarPubMed